These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32629077)

  • 21. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
    Folkert MR; Timmerman RD
    Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis.
    Hegi F; D'Souza M; Azzi M; De Ruysscher D
    Clin Lung Cancer; 2018 May; 19(3):199-212. PubMed ID: 29370978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial).
    Mercier C; Dirix P; Meijnders P; Vermeulen P; Van Laere S; Debois H; Huget P; Verellen D
    Radiat Oncol; 2018 Aug; 13(1):152. PubMed ID: 30126440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
    Siva S; Louie AV; Warner A; Muacevic A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh B; Correa RJ; Lo SS; Staehler M
    Cancer; 2018 Mar; 124(5):934-942. PubMed ID: 29266183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
    Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
    Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review.
    Gouveia AG; Chan DCW; Hoskin PJ; Marta GN; Trippa F; Maranzano E; Chow E; Silva MF
    Radiother Oncol; 2021 Oct; 163():55-67. PubMed ID: 34333087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
    Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer.
    Jung J; Song SY; Kim JH; Yu CS; Kim JC; Kim TW; Jeong SY; Kim SS; Choi EK
    Radiat Oncol; 2015 Nov; 10():238. PubMed ID: 26588896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic ablative body radiotherapy for lung cancer.
    Franks KN; Jain P; Snee MP
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases.
    Corrao G; Marvaso G; Ferrara R; Lo Russo G; Gugliandolo SG; Piperno G; Spaggiari L; De Marinis F; Orecchia R; Garassino MC; Jereczek-Fossa BA
    Lung Cancer; 2020 Apr; 142():70-79. PubMed ID: 32120227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial.
    Chen LC; Chiou WY; Lin HY; Lee MS; Lo YC; Huang LW; Chang CM; Hung TH; Lin CW; Tseng KC; Liu DW; Hsu FC; Hung SK
    BMC Cancer; 2019 Mar; 19(1):275. PubMed ID: 30922261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stereotactic radiation therapy for liver metastases].
    Herfarth KK; Debus J
    Chirurg; 2005 Jun; 76(6):564-9. PubMed ID: 15877214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic Ablative Body Radiotherapy for Lung Metastases: Where is the Evidence and What are We Doing With It?
    Siva S; Slotman BJ
    Semin Radiat Oncol; 2017 Jul; 27(3):229-239. PubMed ID: 28577830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review.
    Chen H; Laba JM; Zayed S; Boldt RG; Palma DA; Louie AV
    J Thorac Oncol; 2019 Aug; 14(8):1332-1342. PubMed ID: 31075543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The optimism surrounding stereotactic body radiation therapy and immunomodulation.
    Tharmalingam H; Hoskin PJ
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S9. PubMed ID: 28917247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
    Olson R; Mathews L; Liu M; Schellenberg D; Mou B; Berrang T; Harrow S; Correa RJM; Bhat V; Pai H; Mohamed I; Miller S; Schneiders F; Laba J; Wilke D; Senthi S; Louie AV; Swaminath A; Chalmers A; Gaede S; Warner A; de Gruijl TD; Allan A; Palma DA
    BMC Cancer; 2020 May; 20(1):380. PubMed ID: 32370765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.
    Esposito M; Maggi G; Marino C; Bottalico L; Cagni E; Carbonini C; Casale M; Clemente S; D'Alesio V; Fedele D; Giglioli FR; Landoni V; Martinotti A; Nigro R; Strigari L; Villaggi E; Mancosu P
    Phys Med; 2016 Jan; 32(1):277-83. PubMed ID: 26498378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
    Bernstein MB; Krishnan S; Hodge JW; Chang JY
    Nat Rev Clin Oncol; 2016 Aug; 13(8):516-24. PubMed ID: 26951040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CyberKnife stereotactic radiosurgery and stereotactic ablative radiation therapy of patients with prostate cancer bone metastases.
    Napieralska A; Miszczyk L; Stapor-Fudzinska M
    Neoplasma; 2016; 63(2):304-12. PubMed ID: 26774153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.